JAZZ vs TNC · P/E 1988, rev $4.07B vs P/E 51, rev $1.29B
Jazz Pharmaceuticals PLC (JAZZ) versus Tennant Company (TNC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Tennant Company (TNC) is a specialty industrial machinery company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TNC revenue for 2024-12-31 was $1.29B. Net income was $83.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
Not investment advice. Open the JAZZ and TNC stock pages for the full models.
Not investment advice.